Mediantechn (ALMDT) - Net Assets
Based on the latest financial reports, Mediantechn (ALMDT) has net assets worth €-35.15 Million EUR (≈ $-41.10 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€35.87 Million ≈ $41.94 Million USD) and total liabilities (€71.02 Million ≈ $83.03 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible equity quality of Mediantechn to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €-35.15 Million |
| % of Total Assets | -97.99% |
| Annual Growth Rate | N/A |
| 5-Year Change | -811.7% |
| 10-Year Change | -190.74% |
| Growth Volatility | 303.71 |
Mediantechn - Net Assets Trend (2008–2025)
This chart illustrates how Mediantechn's net assets have evolved over time, based on quarterly financial data. See defensive interval ratio of Mediantechn to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Mediantechn (2008–2025)
The table below shows the annual net assets of Mediantechn from 2008 to 2025. For live valuation and market cap data, see how much is Mediantechn worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €-35.15 Million ≈ $-41.10 Million |
-3.49% |
| 2024-12-31 | €-33.97 Million ≈ $-39.71 Million |
-230.00% |
| 2023-12-31 | €-10.29 Million ≈ $-12.03 Million |
-41.91% |
| 2022-12-31 | €-7.25 Million ≈ $-8.48 Million |
-246.85% |
| 2021-12-31 | €4.94 Million ≈ $5.77 Million |
+143.47% |
| 2020-12-31 | €-11.36 Million ≈ $-13.28 Million |
-986.96% |
| 2019-12-31 | €1.28 Million ≈ $1.50 Million |
-85.91% |
| 2018-12-31 | €9.09 Million ≈ $10.63 Million |
-63.54% |
| 2017-12-31 | €24.94 Million ≈ $29.15 Million |
-35.62% |
| 2016-12-31 | €38.74 Million ≈ $45.29 Million |
+47.61% |
| 2015-12-31 | €26.24 Million ≈ $30.68 Million |
+90.50% |
| 2014-12-31 | €13.78 Million ≈ $16.11 Million |
-- |
| 2013-12-31 | €0.00 ≈ $0.00 |
-- |
| 2012-12-31 | €0.00 ≈ $0.00 |
-- |
| 2011-12-31 | €5.06 Million ≈ $5.92 Million |
+290.17% |
| 2010-12-31 | €-2.66 Million ≈ $-3.11 Million |
-470.90% |
| 2009-12-31 | €717.62K ≈ $838.98K |
-83.56% |
| 2008-12-31 | €4.37 Million ≈ $5.10 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Mediantechn's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2221693200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €1.84 Million | % |
| Total Equity | €-35.15 Million | 100.00% |
Mediantechn Competitors by Market Cap
The table below lists competitors of Mediantechn ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Exacompta Clairefontaine
PA:ALEXA
|
$183.30 Million |
|
RF Industries Ltd
NASDAQ:RFIL
|
$183.30 Million |
|
inTest Corporation
NYSE MKT:INTT
|
$183.34 Million |
|
GuocoLand (Malaysia) Bhd
KLSE:1503
|
$183.34 Million |
|
Li-FT Power Ltd.
F:WS0
|
$183.25 Million |
|
Associated Alcohols & Breweries Ltd.
NSE:ASALCBR
|
$183.24 Million |
|
Osisko Metals Inc
V:OM
|
$183.11 Million |
|
INKEVERSE GROUP DL-001
F:5IK
|
$183.09 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Mediantechn's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -33,967,000 to -35,151,000, a change of -1,184,000.
- Net loss of 34,069,000 reduced equity.
- New share issuances of 29,453,000 increased equity.
- Other comprehensive income increased equity by 107,283,000.
- Other factors decreased equity by 103,851,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-34.07 Million | -96.92% |
| Share Issuances | €29.45 Million | +83.79% |
| Other Comprehensive Income | €107.28 Million | +305.21% |
| Other Changes | €-103.85 Million | -295.44% |
| Total Change | €- | % |
Book Value vs Market Value Analysis
This analysis compares Mediantechn's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | €0.65 | €5.13 | x |
| 2009-12-31 | €0.13 | €5.13 | x |
| 2010-12-31 | €-0.48 | €5.13 | x |
| 2011-12-31 | €0.87 | €5.13 | x |
| 2012-12-31 | €0.31 | €5.13 | x |
| 2013-12-31 | €-0.18 | €5.13 | x |
| 2014-12-31 | €1.24 | €5.13 | x |
| 2015-12-31 | €2.05 | €5.13 | x |
| 2016-12-31 | €2.82 | €5.13 | x |
| 2017-12-31 | €1.83 | €5.13 | x |
| 2018-12-31 | €0.68 | €5.13 | x |
| 2019-12-31 | €0.11 | €5.13 | x |
| 2020-12-31 | €-0.94 | €5.13 | x |
| 2021-12-31 | €0.32 | €5.13 | x |
| 2022-12-31 | €-0.46 | €5.13 | x |
| 2023-12-31 | €-0.56 | €5.13 | x |
| 2024-12-31 | €-1.84 | €5.13 | x |
| 2025-12-31 | €-0.96 | €5.13 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Mediantechn utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -145.85%
- • Asset Turnover: 0.65x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-123.51%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | -101.77% | -254.81% | 0.25x | 1.60x | €-4.06 Million |
| 2009 | -499.30% | -311.19% | 0.23x | 7.00x | €-3.65 Million |
| 2010 | 0.00% | -295.09% | 0.25x | 0.00x | €-3.11 Million |
| 2011 | -72.12% | -492.30% | 0.07x | 2.07x | €-4.16 Million |
| 2012 | -218.95% | -448.74% | 1.81x | 0.27x | €-4.16 Million |
| 2013 | 0.00% | -361.48% | 2.88x | 0.00x | €-4.24 Million |
| 2014 | -35.16% | -147.59% | 0.18x | 1.30x | €-6.22 Million |
| 2015 | -21.06% | -142.27% | 0.12x | 1.28x | €-8.15 Million |
| 2016 | -23.52% | -143.39% | 0.14x | 1.20x | €-12.98 Million |
| 2017 | -69.00% | -223.86% | 0.23x | 1.37x | €-19.70 Million |
| 2018 | -168.09% | -241.07% | 0.35x | 2.00x | €-16.19 Million |
| 2019 | -623.58% | -89.24% | 0.56x | 12.58x | €-8.12 Million |
| 2020 | 0.00% | -94.97% | 0.53x | 0.00x | €-11.66 Million |
| 2021 | -390.61% | -93.89% | 0.42x | 10.00x | €-19.79 Million |
| 2022 | 0.00% | -85.40% | 0.68x | 0.00x | €-19.49 Million |
| 2023 | 0.00% | -103.40% | 0.62x | 0.00x | €-21.95 Million |
| 2024 | 0.00% | -109.99% | 0.94x | 0.00x | €-21.84 Million |
| 2025 | 0.00% | -145.85% | 0.65x | 0.00x | €-30.55 Million |
Industry Comparison
This section compares Mediantechn's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $22,322,962
- Average return on equity (ROE) among peers: -156.82%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Mediantechn (ALMDT) | €-35.15 Million | -101.77% | N/A | $183.29 Million |
| Affluent Medical SAS (AFME) | $31.47 Million | -49.74% | 0.80x | $110.43 Million |
| Biosynex (ALBIO) | $66.29 Million | 47.32% | 0.90x | $15.74 Million |
| Bluelinea SA (ALBLU) | $2.68 Million | -60.39% | 3.04x | $9.00 Million |
| Carmat (ALCAR) | $1.40 Million | -1250.42% | 5.16x | $6.37 Million |
| Diagnostic Medical Systems SA (ALDMS) | $25.27 Million | -10.60% | 0.84x | $34.47 Million |
| Eurobio Scientific SA (ALERS) | $18.07 Million | -40.63% | 1.08x | $236.10 Million |
| Ikonisys SA (ALIKO) | $15.73 Million | -14.41% | 0.33x | $21.30 Million |
| Implanet SA (ALIMP) | $-174.00K | 0.00% | 0.00x | $28.16 Million |
| Mauna Kea Technologies SAS (ALMKT) | $40.16 Million | -32.51% | 0.22x | $28.43 Million |
About Mediantechn
Median Technologies SA engages in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development with operations spanning in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iSee for imaging services in clinical trials; eyonis for non-invasive diagnos… Read more